Hyperion Defi HYPD
NASDAQ HYPD
$3.14 +0.10 (+3.29%)
At close: Aug 20, 2026 · 4:00 PM EDT

Hyperion Defi (HYPD) Total Current Liabilities (2016 - 2026)

Hyperion Defi (HYPD) posted quarterly Total Current Liabilities of $4.5 million for Q1 2026, down 70.38% year-over-year from $15.1 million in Q1 2025, and up 65.61% quarter-over-quarter from $2.7 million in Q4 2025.

Hyperion Defi (HYPD) Total Current Liabilities (2016 - 2026) Analysis & Trends

Hyperion Defi (HYPD) has reported Total Current Liabilities for 11 consecutive years, with $4.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 70.38% year-over-year to $4.5 million; the TTM figure through Mar 2026 stood at $4.5 million (down 70.38% YoY), while the FY2025 annual figure was $2.7 million, down 83.17% from the prior year.
  • Total Current Liabilities advanced to $4.5 million in Q1 2026 per HYPD's latest filing, from $2.7 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $16.5 million in Q1 2024 and bottomed at $2.7 million in Q4 2025.
  • Historically, Total Current Liabilities has averaged $9.6 million across 5 years, with a median of $10.3 million in 2025.
  • Annual changes were most pronounced in 2024 — Total Current Liabilities soared 289.96% — and 2025, when it tumbled 83.17%.
  • Hyperion Defi's Total Current Liabilities stood at $4.5 million in 2022, then soared by 111.21% to $9.5 million in 2023, then soared by 68.37% to $16.0 million in 2024, then sank by 83.17% to $2.7 million in 2025, then soared by 65.61% to $4.5 million in 2026.
  • Business Quant data shows HYPD's Total Current Liabilities at $4.5 million in Q1 2026, $2.7 million in Q4 2025, and $4.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.58 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.51 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 438.74 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 630.93 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 2.49 Bn
10 Hyperion Defi 44.65 Mn 35.01 Mn 357,693.00 5.51 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 5.51 Mn
Mar 31, 2026 4.47 Mn
Dec 31, 2025 2.70 Mn
Sep 30, 2025 4.04 Mn
Jun 30, 2025 10.31 Mn
Mar 31, 2025 15.10 Mn
Dec 31, 2024 16.05 Mn
Sep 30, 2024 15.78 Mn
Jun 30, 2024 15.85 Mn
Mar 31, 2024 16.46 Mn
Dec 31, 2023 9.53 Mn
Sep 30, 2023 6.55 Mn
Jun 30, 2023 4.06 Mn
Mar 31, 2023 4.90 Mn
Dec 31, 2022 4.51 Mn
Sep 30, 2022 11.02 Mn
Jun 30, 2022 11.98 Mn
Mar 31, 2022 10.38 Mn
Dec 31, 2021 11.17 Mn
Sep 30, 2021 20.72 Mn